{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:28:38Z","timestamp":1790904518133,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"reseachers supporting project","award":["RSP2022R235"],"award-info":[{"award-number":["RSP2022R235"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-78244-2","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T04:08:02Z","timestamp":1730952482000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Self-assembled latanoprost loaded soluplus nanomicelles as an ophthalmic drug delivery system for the management of glaucoma"],"prefix":"10.1038","volume":"14","author":[{"given":"Shazma","family":"Gohar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafar","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazli","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzna Ali","family":"Khattak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gul","family":"e Maryam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Pervez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawaz","family":"Alasmari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Neau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda Rabqa","family":"Zainab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arbab Tahir","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altaf","family":"ur Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"78244_CR1","first-page":"225","volume":"117","author":"AK Schuster","year":"2020","unstructured":"Schuster, A. K., Erb, C., Hoffmann, E. M., Dietlein, T. & Pfeiffer, N. The diagnosis and treatment of glaucoma. Dtsch. Arztebl Int. 117, 225 (2020).","journal-title":"Dtsch. Arztebl Int."},{"key":"78244_CR2","doi-asserted-by":"publisher","first-page":"e24513","DOI":"10.1371\/journal.pone.0024513","volume":"6","author":"JV Natarajan","year":"2011","unstructured":"Natarajan, J. V. et al. Sustained release of an anti-glaucoma drug: Demonstration of efficacy of a liposomal formulation in the rabbit eye. PloS One 6, e24513 (2011).","journal-title":"PloS One"},{"key":"78244_CR3","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/bph.14327","volume":"176","author":"PG Klimko","year":"2019","unstructured":"Klimko, P. G. & Sharif, N. A. Discovery, characterization and clinical utility of prostaglandin agonists for the treatment of glaucoma. Br. J. Pharmacol. 176, 1051\u20131058 (2019).","journal-title":"Br. J. Pharmacol."},{"key":"78244_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/APO.0000000000000181","volume":"5","author":"A Cheema","year":"2016","unstructured":"Cheema, A., Chang, R. T., Shrivastava, A. & Singh, K. Update on the medical treatment of primary open-angle glaucoma. Asia Pac. J. Ophthalmol. 5, 51\u201358 (2016).","journal-title":"Asia Pac. J. Ophthalmol."},{"key":"78244_CR5","doi-asserted-by":"crossref","unstructured":"Alm, A. Latanoprost in the treatment of glaucoma. Clin Ophthalmol. 1967\u20131985 (2014).","DOI":"10.2147\/OPTH.S59162"},{"key":"78244_CR6","first-page":"897","volume":"2","author":"A Russo","year":"2008","unstructured":"Russo, A., Riva, I., Pizzolante, T., Noto, F. & Quaranta, L. Latanoprost ophthalmic solution in the treatment of open angle glaucoma or raised intraocular pressure: A review. Clin. Ophthalmol. 2, 897\u2013905 (2008).","journal-title":"Clin. Ophthalmol."},{"key":"78244_CR7","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1080\/00032710600755330","volume":"39","author":"M Ashfaq","year":"2006","unstructured":"Ashfaq, M., Khan, I. U. & Asghar, M. N. High-performance liquid chromatography determination of latanoprost in pharmaceutical formulations using UV detection. Anal. Lett. 39, 2235\u20132242 (2006).","journal-title":"Anal. Lett."},{"key":"78244_CR8","first-page":"656","volume":"40","author":"S Sawatdee","year":"2013","unstructured":"Sawatdee, S., Phetmung, H. & Srichana, T. Development of a stable latanoprost solution for use as eye drops. Chiang Mai J. Sci. 40, 656\u2013668 (2013).","journal-title":"Chiang Mai J. Sci."},{"key":"78244_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ejpb.2015.04.032","volume":"95","author":"M Rodriguez-Aller","year":"2015","unstructured":"Rodriguez-Aller, M. et al. New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance. Eur. J. Pharm. Biopharm. 95, 203\u2013214 (2015).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"78244_CR10","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jddst.2017.08.011","volume":"41","author":"RR Horne","year":"2017","unstructured":"Horne, R. R., Judd, K. E. & Pitt, W. G. Rapid loading and prolonged release of latanoprost from a silicone hydrogel contact lens. J. Drug Deliv. Sci. Technol. 41, 410\u2013418 (2017).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"78244_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/00061198-200110000-00007","volume":"10","author":"PV Morgan","year":"2001","unstructured":"Morgan, P. V., Proniuk, S., Blanchard, J. & Noecker, R. J. Effect of temperature and light on the stability of latanoprost and its clinical relevance. J. Glaucoma 10, 401\u2013405 (2001).","journal-title":"J. Glaucoma"},{"key":"78244_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.15171\/bi.2016.07","volume":"6","author":"J Barar","year":"2016","unstructured":"Barar, J., Aghanejad, A., Fathi, M. & Omidi, Y. Advanced drug delivery and targeting technologies for the ocular diseases. BioImpacts BI. 6, 49 (2016).","journal-title":"BioImpacts: BI"},{"key":"78244_CR13","first-page":"100","volume":"2","author":"HA Patel","year":"2010","unstructured":"Patel, H. A., Patel, J. K., Patel, K. N. & Patel, R. R. Ophthalmic drug delivery system\u2014A review. Der Pharmacia Lettre 2, 100\u2013115 (2010).","journal-title":"Der Pharmacia Lettre"},{"key":"78244_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.addr.2017.04.001","volume":"122","author":"DR Janagam","year":"2017","unstructured":"Janagam, D. R., Wu, L. & Lowe, T. L. Nanoparticles for drug delivery to the anterior segment of the eye. Adv. Drug Deliv. Rev. 122, 31\u201364 (2017).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"78244_CR15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","volume":"12","author":"R Gaudana","year":"2010","unstructured":"Gaudana, R., Ananthula, H. K., Parenky, A. & Mitra, A. K. Ocular drug delivery. AAPS J. 12, 348\u2013360 (2010).","journal-title":"AAPS J."},{"key":"78244_CR16","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3109\/10717544.2014.943336","volume":"23","author":"R Agarwal","year":"2016","unstructured":"Agarwal, R. et al. Liposomes in topical ophthalmic drug delivery: An update. Drug Deliv. 23, 1075\u20131091 (2016).","journal-title":"Drug Deliv"},{"key":"78244_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4155\/tde.12.122","volume":"4","author":"AD Vadlapudi","year":"2013","unstructured":"Vadlapudi, A. D. & Mitra, A. K. Nanomicelles: An emerging platform for drug delivery to the eye. Ther. Deliv. 4, 1\u20133 (2013).","journal-title":"Ther. Deliv"},{"key":"78244_CR18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2217\/nnm.10.10","volume":"5","author":"R Trivedi","year":"2010","unstructured":"Trivedi, R. & Kompella, U. B. Nanomicellar formulations for sustained drug delivery: Strategies and underlying principles. Nanomed 5, 485\u2013505 (2010).","journal-title":"Nanomed"},{"key":"78244_CR19","first-page":"42","volume":"10","author":"P Velagaleti","year":"2010","unstructured":"Velagaleti, P., Anglade, E., Khan, I., Gilger, B. & Mitra, A. Topical delivery of hydrophobic drugs using a novel mixed nanomicellar technology to treat diseases of the anterior and posterior segments of the eye. Drug Deliv Technol. 10, 42\u201347 (2010).","journal-title":"Drug Deliv Technol."},{"key":"78244_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jiec.2017.06.050","volume":"55","author":"N Amirmahani","year":"2017","unstructured":"Amirmahani, N., Mahmoodi, N. O., Galangash, M. M. & Ghavidast A. advances in nanomicelles for sustained drug delivery. J. Industrial Eng. Chem. 55, 21\u201334 (2017).","journal-title":"J. Industrial Eng. Chem."},{"key":"78244_CR21","first-page":"82","volume":"2","author":"K Cholkar","year":"2012","unstructured":"Cholkar, K., Patel, A., Dutt Vadlapudi, A. & Mitra, K. Novel nanomicellar formulation approaches for anterior and posterior segment ocular drug delivery. Recent. Pat. Nanotechnol. 2, 82\u201395 (2012).","journal-title":"Recent. Pat. Nanotechnol"},{"key":"78244_CR22","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.3109\/10717544.2015.1116025","volume":"23","author":"X Wang","year":"2016","unstructured":"Wang, X., Wang, S. & Zhang, Y. Advance of the application of nano-controlled release system in ophthalmic drug delivery. Drug Deliv. 23, 2897\u20132901 (2016).","journal-title":"Drug Deliv"},{"key":"78244_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1556-276X-9-684","volume":"9","author":"L Dian","year":"2014","unstructured":"Dian, L. et al. Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles. Nanoscale Res. Lett. 9, 1\u201311 (2014).","journal-title":"Nanoscale Res. Lett."},{"key":"78244_CR24","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1080\/03639045.2017.1349787","volume":"43","author":"M Li","year":"2017","unstructured":"Li, M., Xin, M., Guo, C., Lin, G. & Wu, X. New Nanomicelle curcumin formulation for ocular delivery: Improved stability, solubility, and ocular anti-inflammatory treatment. Drug Dev. Ind. Pharm. 43, 1846\u20131857 (2017).","journal-title":"Drug Dev. Ind. Pharm."},{"key":"78244_CR25","first-page":"1","volume":"5","author":"C Guo","year":"2015","unstructured":"Guo, C. et al. Nanomicelle formulation for topical delivery of cyclosporine A into the cornea: In vitro mechanism and in vivo permeation evaluation. Sci. Rep. 5, 1\u201314 (2015).","journal-title":"Sci. Rep."},{"key":"78244_CR26","first-page":"208","volume":"10","author":"G Noh","year":"2018","unstructured":"Noh, G. et al. Development and evaluation of a water soluble fluorometholone eye drop formulation employing polymeric micelle. Pharm 10, 208 (2018).","journal-title":"Pharm"},{"key":"78244_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/IJG.0b013e31814b990d","volume":"17","author":"D Ghate","year":"2008","unstructured":"Ghate, D. & Edelhauser, H. F. Barriers to glaucoma drug delivery. J. Glaucoma 17, 147\u2013156 (2008).","journal-title":"J. Glaucoma"},{"key":"78244_CR28","first-page":"1512","volume":"104","author":"A Hedengran","year":"2020","unstructured":"Hedengran, A., Steensberg, A. T., Virgili, G., Azuara-Blanco, A. & Kolko, M. Efficacy and safety evaluation of benzalkonium chloride preserved eye-drops compared with alternatively preserved and preservative-free eye-drops in the treatment of glaucoma: A systematic review and meta-analysis. Br. J. Ophthalmol. 104, 1512\u20131518 (2020).","journal-title":"Br. J. Ophthalmol."},{"key":"78244_CR29","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1442-9071.2004.00782.x","volume":"32","author":"SH Cha","year":"2004","unstructured":"Cha, S. H., Lee, J. S., Oum, B. S. & Kim, C. D. Corneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitro. Clin. Experimental Ophthalmol. 32, 180\u2013184 (2004).","journal-title":"Clin. Experimental Ophthalmol."},{"key":"78244_CR30","doi-asserted-by":"crossref","unstructured":"Halder, A. & Khopade, A. J. Physiochemical properties and cytotoxicity of a benzalkonium chloride-free, micellar emulsion ophthalmic formulation of latanoprost. Clin. Ophthalmol. 3057\u20133064 (2020).","DOI":"10.2147\/OPTH.S266453"},{"key":"78244_CR31","doi-asserted-by":"publisher","first-page":"100901","DOI":"10.1016\/j.preteyeres.2020.100901","volume":"82","author":"UB Kompella","year":"2021","unstructured":"Kompella, U. B., Hartman, R. R. & Patil, M. A. Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma. Progress Retinal eye Res. 82, 100901 (2021).","journal-title":"Progress Retinal eye Res."},{"key":"78244_CR32","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1080\/03639045.2020.1755305","volume":"46","author":"D Fathalla","year":"2020","unstructured":"Fathalla, D., Fouad, E. A. & Soliman, G. M. Latanoprost niosomes as a sustained release ocular delivery system for the management of glaucoma. Drug Dev. Industrial Pharm. 46, 806\u2013813 (2020).","journal-title":"Drug Dev. Industrial Pharm."},{"key":"78244_CR33","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1080\/03639045.2020.1755305","volume":"46","author":"D Fathalla","year":"2020","unstructured":"Fathalla, D., Fouad, E. A. & Soliman, G. M. Latanoprost niosomes as a sustained release ocular delivery system for the management of glaucoma. Drug Dev. Ind. Pharm. 46, 806\u2013813 (2020).","journal-title":"Drug Dev. Ind. Pharm."},{"key":"78244_CR34","first-page":"20","volume":"17","author":"NP Nadpara","year":"2012","unstructured":"Nadpara, N. P., Thumar, R. V., Kalola, V. N. & Patel, P. B. Quality by design (QBD): A complete review. Int. J. Pharm. Sci. Rev. Res. 17, 20\u201328 (2012).","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"key":"78244_CR35","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/17425247.2018.1504768","volume":"15","author":"V Mishra","year":"2018","unstructured":"Mishra, V., Thakur, S., Patil, A. & Shukla, A. Quality by design (QbD) approaches in current pharmaceutical set-up. Expert Opin. Drug Deliv. 15, 737\u2013758 (2018).","journal-title":"Expert Opin. Drug Deliv."},{"key":"78244_CR36","unstructured":"Schwartz, J. B., O\u2019Connor, R. E. & Schnaare, R. L. In Modern Pharmaceutics 921\u2013950 (CRC, 2002)."},{"key":"78244_CR37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.4103\/1735-5362.263554","volume":"14","author":"A Salimi","year":"2019","unstructured":"Salimi, A., Zadeh, B. S. M. & Kazemi, M. Preparation and optimization of polymeric micelles as an oral drug delivery system for deferoxamine mesylate: In vitro: and: Ex vivo: Studies. Res. Pharm. Sci. 14, 293\u2013307 (2019).","journal-title":"Res. Pharm. Sci."},{"key":"78244_CR38","first-page":"29","volume":"112","author":"A Giarmoukakis","year":"2013","unstructured":"Giarmoukakis, A. et al. Biodegradable nanoparticles for controlled subconjunctival delivery of latanoprost acid: In vitro and in vivo evaluation. Preliminary Results 112, 29\u201336 (2013).","journal-title":"Preliminary Results"},{"key":"78244_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1211\/jpp.58.1.0006","volume":"58","author":"Z Liu","year":"2006","unstructured":"Liu, Z., Nie, S., Guo, H., Pan, W. & Li, J. Effects of Transcutol P on the corneal permeability of drugs and evaluation of its ocular irritation of rabbit eyes. J. Pharm. Pharmacol. 58, 45\u201350 (2006).","journal-title":"J. Pharm. Pharmacol."},{"key":"78244_CR40","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.tox.2014.11.003","volume":"327","author":"SL Wilson","year":"2015","unstructured":"Wilson, S. L., Ahearne, M. & Hopkinson, A. An overview of current techniques for ocular toxicity testing. Toxicology 327, 32\u201346 (2015).","journal-title":"Toxicology"},{"key":"78244_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0168-3659(02)00284-5","volume":"85","author":"V Baeyens","year":"2002","unstructured":"Baeyens, V. et al. Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI\u00ae) for the treatment of external ocular infections in dogs. J. Control Release 85, 163\u2013168 (2002).","journal-title":"J. Control Release"},{"key":"78244_CR42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/0301-4738.109384","volume":"61","author":"S Bhartiya","year":"2013","unstructured":"Bhartiya, S., Bali, S. J., James, M., Panda, A. & Dada, T. Test retest variability of TonoPen AVIA. Indian J. Ophthalmol. 61, 129\u2013131 (2013).","journal-title":"Indian J. Ophthalmol."},{"key":"78244_CR43","doi-asserted-by":"publisher","first-page":"105735","DOI":"10.1016\/j.ejps.2021.105735","volume":"159","author":"N Mehra","year":"2021","unstructured":"Mehra, N., Aqil, M. & Sultana, Y. A grafted copolymer-based nanomicelles for topical ocular delivery of everolimus: Formulation, characterization, ex-vivo permeation, in-vitro ocular toxicity, and stability study. Eur. J. Pharm. Sci. 159, 105735 (2021).","journal-title":"Eur. J. Pharm. Sci."},{"key":"78244_CR44","unstructured":"Bhuptani, R. S. et al. Soluplus based polymeric micelles and mixed micelles of lornoxicam: design, characterization and in vivo efficacy studies in rats. Indian J. Pharm. Educ. Res. 50 (2016)."},{"key":"78244_CR45","first-page":"623","volume":"40","author":"M Nemati","year":"2022","unstructured":"Nemati, M., Fathi-Azarbayjani, A., Al\u2010Salami, H., Roshani Asl, E. & Rasmi, Y. Bile acid\u2010based advanced drug delivery systems, bilosomes and micelles as novel carriers for therapeutics. Cell. Biochem. 40, 623\u2013635 (2022).","journal-title":"Cell. Biochem."},{"key":"78244_CR46","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.3390\/pharmaceutics15082019","volume":"15","author":"S Pervez","year":"2023","unstructured":"Pervez, S. et al. Transdermal delivery of glimepiride: A novel approach using nanomicelle-embedded microneedles. Pharmaceutics 15, 2019 (2023).","journal-title":"Pharmaceutics"},{"key":"78244_CR47","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3390\/polym14061241","volume":"14","author":"S Jia","year":"2022","unstructured":"Jia, S. et al. Stabilizing effect of Soluplus on Erlotinib metastable crystal form in microparticles and amorphous solid dispersions. Polymers 14, 1241 (2022).","journal-title":"Polymers"},{"key":"78244_CR48","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3390\/ph16050677","volume":"16","author":"T Hidayatullah","year":"2023","unstructured":"Hidayatullah, T. et al. Hybrid dissolving microneedle-mediated delivery of ibuprofen: Solubilization, fabrication, and characterization. Pharmaceuticals 16, 677 (2023).","journal-title":"Pharmaceuticals"},{"key":"78244_CR49","doi-asserted-by":"publisher","first-page":"12968","DOI":"10.1038\/srep12968","volume":"5","author":"C Guo","year":"2015","unstructured":"Guo, C. et al. Nanomicelle formulation for topical delivery of cyclosporine A into the cornea: In vitro mechanism and in vivo permeation evaluation. Sci. Rep. 5, 12968 (2015).","journal-title":"Sci. Rep."},{"key":"78244_CR50","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/toxsci\/kfg242","volume":"76","author":"MH Abraham","year":"2003","unstructured":"Abraham, M. H. et al. Draize rabbit eye test compatibility with eye irritation thresholds in humans: A quantitative structure-activity relationship analysis. Toxicol. Sci. 76, 384\u2013391 (2003).","journal-title":"Toxicol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78244-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78244-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78244-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T12:02:47Z","timestamp":1735300967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78244-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["78244"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-78244-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"1 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with ARRIVE guidelines and approved by the ethical committee of the Department of Pharmacy, university of Peshawar (approval number <b>423\/EC\/F.LIFE\/UOP-2021<\/b>).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}},{"value":"All subjects participating in the study provided informed consent along with written consent to publish the data in paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"27051"}}